Smoking Cessation Resource Center Helping professionals help their patients quit smoking Home Our Products Literature Resources GSK Commitment Contact Us
Commit Photo
Commit™ provides proven quit power even for those patients with a history of previous unsuccessful pharmacological quit attempts or patients who are heavily nicotine dependent.1,2 Commit 4 mg significantly reduces weight gain associated with quitting1 * which can be a barrier to successful quit attempts.2

Learn more about Commit

Nicorette Photo
For your patients trying to quit smoking, only Nicorette® allows an extra piece to help control their acute, extra cravings. Unlike other smoking control products, Nicorette® allows patients up to 24 pieces daily to fight cravings. Nicorette gives patients more active control over quitting, and is available in mint, freshmint, original, and orange flavors.

Learn more about Nicorette


NicoDerm Photo
NicoDerm® CQ® can help your more nicotine-dependent patients with up to 24-hour power to help quit smoking. This convenient, once-a-day transdermal patch helps calm even morning cravings and provides step-down dosing recommended by smoking cessation experts to gradually wean patients off nicotine.

Learn more about NicoDerm CQ


1 Shiffman, S, Dresler CM, Rohary JM. Successful treatment with nicotine lozenge of smokers with prior failure in pharmacological therapy. Addiction. 2004 Jan;99 (1); 83-92.

2 Fiore MC. Bailey WC, Cohen SJ, et al. Clinical Practice Guideline: Treating Tobacco Use and Dependence. Rockville, MD: Public Health Service, US Department of Health and Human Services; June 2000.

*Results with Commit 4mg lozenge and during treatment period only. Mean change in body weight (kg) Commit 4 mg 1.27, placebo 2.30 at 6 weeks (P<0.001) and Commit 4 mg 2.67, placebo 3.40 at 12 weeks (P=0.04).



GlaxoSmithKline Consumer Healthcare Commit NicoDerm CQ Nicorette


This site is intended for U.S. healthcare professionals only · Privacy Statement · Copyright © GlaxoSmithKline.